Shares of Guardant Health Inc. (GH) fell sharply by 5.11% in the pre-market session on Friday, as the company reported disappointing financial results for the quarter ended December 31, 2024.
According to the earnings report, Guardant Health posted an adjusted loss of $0.90 per share, missing analysts' expectations of a loss of $0.74 per share. The company's revenue grew 30.2% year-over-year to $201.81 million, but still fell short of the consensus estimate of $192.14 million.
The disappointing earnings performance and failure to meet Wall Street's estimates appear to have triggered the sharp sell-off in Guardant Health's stock. Investors may have concerns about the company's profitability and growth prospects, as it continues to report significant losses despite revenue growth.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。